abstract |
Pyrolothriazine kinase inhibitors. The present invention relates to compounds of formula 1 and pharmaceutically acceptable salts thereof. The compounds of formula 1 inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease. |